Peg-interferon plus ribavirin in chronic hepatitis C: cost-efficacy and pharmacoutilization in clinical practice. (2008). Farmeconomia. Health Economics and Therapeutic Pathways, 9(4), 173-181. https://doi.org/10.7175/fe.v9i4.235